Erle T. Mast

Erle T. Mast has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Clovis Oncology, Inc., Somaxon Pharmaceuticals, Inc. and Zogenix, Inc. The record holds 99 filings, for trades running from 24 February 2006 to 7 March 2022.

In open-market terms, that means 11 purchases worth €205k on one side and 54 sales worth €6.5M on the other. The net balance comes to €6.3M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 14 share grants and 11 option exercises. 2022 to date brings no purchases and 2 sales.

A typical purchase (the median) is worth €8,888.

The latest filing, published on 9 March 2022, reports a transaction in Zogenix, Inc. The last purchase on record was published on 1 August 2017, which is 3,370 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.